デフォルト表紙
市場調査レポート
商品コード
1458413

動物感染症診断市場の評価:技術・動物タイプ・感染タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)

Veterinary Infectious Disease Diagnostics Market Assessment, By Technology, By Animal Type, By Infection Type, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 231 Pages | 納期: 3~5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
動物感染症診断市場の評価:技術・動物タイプ・感染タイプ・エンドユーザー・地域別の機会および予測 (2017-2031年)
出版日: 2024年04月01日
発行: Market Xcel - Markets and Data
ページ情報: 英文 231 Pages
納期: 3~5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の動物感染症診断の市場規模は、2023年の21億1,000万米ドルから、2024年から2031年の予測期間中は9.25%のCAGRで推移し、2031年には42億8,000万米ドルの規模に成長すると予測されています。

市場拡大の背景には、コンパニオンアニマルの飼育の増加、R&D活動の活発化、食肉製品の消費の拡大、人畜共通感染症の流行増加があります。

コンパニオンアニマルの人気の高まり:

コンパニオンアニマルの飼育が増加しているのは、無条件の愛や忠誠心など、コンパニオンアニマルが示すさまざまな情緒的利点に起因しています。これらの動物はまた、世話をする人がより活動的で健康的なライフスタイルを送ることができるようになるなど、さまざまな健康上の利点も提供します。コンパニオンアニマルは、うつ病、ストレス、孤立、不安、恐怖など、精神疾患を患う人々を悩ませるさまざまな負の感情を軽減することが証明されています。また、ポジティブな感情を高めるための強力な化学物質を脳と体に与えてくれます。コンパニオンアニマルは、精神疾患を抱える人々に平常心を与え、日常生活を安定させるため、飼育が増えています。

R&D活動の増加:

斬新で先進的な診断ソリューションの開発に向けた投資と、中小企業や新興企業の台頭の増加が、市場に有利な成長機会をもたらしています。このような活動は、世界各地における動物医療インフラの急速な拡大によっても促進されています。診断の道程において、R&D活動は、コンセプトやアイデアを診断技術やツールに変換することで、さまざまな課題に取り組む研究者を支援します。

北米が大きな市場シェアを占める見込み:

高度な診断ソリューションのアベイラビリティの増加、可処分所得の高さ、ペット保険の人気の高まり、ペットやコンパニオンアニマルの飼育の増加が、北米の動物感染症診断市場の成長を支える主な要因の一部です。Forbesによると、米国におけるペットの飼育率は過去数年間で大幅に上昇しました。2024年現在、同国の世帯の約66%がペットを飼っていると推定されています。さまざな主要参入企業の強力なプレゼンスとペット医療インフラの拡大により、斬新な製品とサービスのアベイラビリティが高まっていることが、北米の市場需要をさらに押し上げています。

当レポートでは、世界の動物感染症診断の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の動物感染症診断市場の展望

  • 市場規模・予測
  • 技術別
    • 分子診断
    • 免疫診断
    • 尿検査
    • 血液学
    • その他
  • 動物タイプ別
    • 食用動物
    • ペット
  • 感染タイプ別
    • ウイルス感染
    • 寄生虫感染症
    • 細菌感染症
    • その他
  • エンドユーザー別
    • 獣医ラボ・診療所
    • ポイントオブケア/院内検査
    • リファレンスラボ
    • その他
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 企業別市場シェア

第5章 世界の動物感染症診断市場の展望:地域別

  • 北米
  • 南米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ

第6章 市場マッピング

  • 航空機タイプ別
  • タイプ別
  • エンドユーザー別
  • サブフレームワーク別
  • 地域別

第7章 マクロ環境と産業構造

  • 需給分析
  • 輸入輸出分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第8章 市場力学

  • 成長促進要因
  • 成長抑制要因 (課題と抑制)

第9章 規制の枠組みとイノベーション

  • 特許情勢
  • 規制当局の承認
  • イノベーション/新興技術

第10章 主要企業の情勢

  • 市場リーダー上位5社の競合マトリックス
  • 市場リーダー上位5社の市場収益分析
  • M&A・ジョイントベンチャー (該当する場合)
  • SWOT分析(参入5社)
  • 特許分析(該当する場合)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の展望

  • Biomerieux S.A.
  • Zoetis, Inc.
  • IDEXX Laboratories, Inc.
  • Indical Bioscience
  • Heska Corporation
  • IDVet
  • Thermo Fisher Scientific Inc.
  • Virbac
  • Randox Laboratories Ltd.
  • Neogen Corporation

第14章 戦略的提言

第15章 当社について・免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1.Global Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2.Global Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 3.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 4.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 5.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 6.Global Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 7.Global Veterinary Infectious Disease Diagnostics Market Share (%), By Region, 2017-2031F
  • Figure 8.North America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 9.North America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 10.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 11.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 12.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 13.North America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 14.North America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 15.United States Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16.United States Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 17.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 18.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 19.United States Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 20.United States Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 21.Canada Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 22.Canada Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 23.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 24.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 25.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 26.Canada Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 27.Mexico Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 28.Mexico Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 29.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 30.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 31.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 32.Mexico Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 33.Europe Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 34.Europe Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 35.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 36.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 37.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 38.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 39.Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 40.Germany Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41.Germany Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 42.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 43.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 44.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 45.Germany Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 46.France Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 47.France Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 48.France Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 49.France Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 50.France Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 51.France Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 52.Italy Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53.Italy Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 54.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 55.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 56.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 57.Italy Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 58.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 59.United Kingdom Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 60.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 61.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 62.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 63.United Kingdom Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 64.Russia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65.Russia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 66.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 67.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 68.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 69.Russia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 70.Netherlands Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 71.Netherlands Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 72.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 73.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 74.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 75.Netherlands Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 76.Spain Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 77.Spain Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 78.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 79.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 80.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 81.Spain Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 82.Turkey Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83.Turkey Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 84.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 85.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 86.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 87.Turkey Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 88.Poland Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 89.Poland Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 90.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 91.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 92.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 93.Poland Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 94.South America Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95.South America Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 96.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 97.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 98.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 99.South America Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 100.South America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 101.Brazil Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 102.Brazil Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 103.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 104.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 105.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 106.Brazil Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 107.Argentina Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 108.Argentina Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 109.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 110.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 111.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 112.Argentina Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 113.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 114.Asia-Pacific Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 115.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 116.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 117.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 118.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 119.Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 120.India Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 121.India Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 122.India Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 123.India Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 124.India Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 125.India Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 126.China Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 127.China Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 128.China Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 129.China Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 130.China Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 131.China Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 132.Japan Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 133.Japan Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 134.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 135.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 136.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 137.Japan Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 138.Australia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 139.Australia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 140.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 141.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 142.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 143.Australia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 144.Vietnam Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 145.Vietnam Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 146.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 147.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 148.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 149.Vietnam Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 150.South Korea Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 151.South Korea Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 152.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 153.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 154.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 155.South Korea Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 156.Indonesia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 157.Indonesia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 158.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 159.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 160.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 161.Indonesia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 162.Philippines Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 163.Philippines Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 164.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 165.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 166.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 167.Philippines Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 168.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 169.Middle East & Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 170.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 171.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 172.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 173.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 174.Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Country, 2017-2031F
  • Figure 175.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 176.Saudi Arabia Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 177.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 178.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 179.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 180.Saudi Arabia Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 181.UAE Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 182.UAE Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 183.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 184.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 185.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 186.UAE Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 187.South Africa Veterinary Infectious Disease Diagnostics Market, By Value, In USD Billion, 2017-2031F
  • Figure 188.South Africa Veterinary Infectious Disease Diagnostics Market, By Volume, In Million Units, 2017-2031F
  • Figure 189.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, 2017-2031F
  • Figure 190.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal Type, 2017-2031F
  • Figure 191.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Infection Type, 2017-2031F
  • Figure 192.South Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-user, 2017-2031F
  • Figure 193.By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 194.By Animal Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 195.By Infection Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 196.By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 197.By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
目次
Product Code: MX11210

Global veterinary infectious disease diagnostics market is projected to witness a CAGR of 9.25% during the forecast period 2024-2031, growing from USD 2.11 billion in 2023 to USD 4.28 billion in 2031. The market expansion is supported by increasing adoption of companion animals, rising research and development activities, growing consumption of meat products, and increasing prevalence of zoonotic diseases.

The increasing adoption of pets due to rising nuclear households and urbanization is propelling the requirement for veterinary infectious disease diagnostic devices and solutions. Pet owners are extremely invested in the health and well-being of their pets and ensure that they are provided with essential veterinary care. The rise in demand for veterinary infectious disease diagnostic solutions can also be attributed to the growing prevalence of various vector-borne and zoonotic diseases due to climate change, the introduction of exotic vectors, and habitat modification. To combat the spread of such diseases, the requirement for precise and rapid diagnostic tools is increasing, boosting the market expansion.

The market is also expected to witness significant growth over the forecast period owing to enhanced capabilities of diagnostic devices and the increasing availability of technologically advanced diagnostic methods, including RTPCR. Furthermore, the growing popularity of pet insurance and increasing concerns about the wellbeing of pets, coupled with rising disposable incomes, is bolstering the market growth. Growing awareness about regular health checkups for animals is also boosting the market demand. According to Forbes, approximately 5.36 million pets are insured in America, of which 20% are cats and 80% are dogs.

Growing Popularity of Companion Animals

The increased adoption of companion animals can be attributed to the various emotional benefits offered by them, including unconditional love and loyalty. These animals also offer various health benefits, including empowering their caretakers to lead more active and healthier lifestyles. Companion animals have been proven to reduce different overwhelming negative emotions that trouble those with mental illnesses, such as depression, stress, isolation, anxiety, and fear. They also provide the brain and body with powerful chemicals for boosting positive emotions. The adoption of companion animals is also increasing as they provide a sense of consistency and normalcy, stabilizing routines to individuals living with mental illness.

According to the Progressive Animal Welfare Services (PAWS), approximately one in five Canadians live with some form of mental illness as per the Mental Health Commission of Canada. It is estimated that 8.9 million Canadians (almost 23% of the country's population) will be suffering from some sort of mental illness by 2041.

Increasing Research and Development Activities

Growing investments towards the development of novel and advanced diagnostic solutions and the increasing emergence of smaller companies and startups are providing lucrative growth opportunities to the market. Such activities are also promoted by the rapid expansion of the animal healthcare infrastructure in various regions across the globe. In the diagnostic journey, research and development activities aid researchers in addressing the different challenges by translating concepts and ideas into diagnostic technologies and tools, which can then be used for identifying different infectious diseases in animals. Over the past few years, small companies and startups, including Wellness Ready, have increased their efforts toward introducing products essential for conducting point-of-care tests in veterinary medicine. Due to the different advantages associated with point-of-care tests, such as minimal sample processing, elimination of sample transportation, minimal sample requirement, and simple analytic process, their demand has been increasing for diagnosing veterinary infectious diseases.

North America Expected to Account for Significant Market Share

The increasing availability of advanced diagnostic solutions, high disposable incomes, the growing popularity of pet insurance, and rising adoption of pets and companion animals are some of the major factors supporting the North America veterinary infectious disease diagnostics market growth. According to Forbes, pet ownership in the United States significantly increased over the past few years. It is estimated that, as of 2024, approximately 66% of the households in the country own a pet. The increasing availability of novel products and services, owing to the strong presence of various key market players and the growing expansion of pet healthcare infrastructure, is further boosting the market demand in North America. Due to the growing consumption of dairy products and meat in the region and increasing awareness about the importance of maintaining the health of food-producing animals, emphasis is being put on ensuring animal health. As per the estimates of the U.S. Department of Agriculture, in 2021, 56.2 pounds of beef per person were available in the United States for human consumption and 68.1 pounds of chicken per person were available.

Immunodiagnostics to Witness Significant Expansion

The expansion of the segment can be attributed to the increased development of advanced diagnostic solutions, platforms, and novel immunoassay formats. The rising utilization of immunoassays for testing infectious diseases, the growing popularity of automation, and increasing concerns about animal fitness and health are further boosting the growth of the segment. The efforts towards enhancing the accuracy of immunoassay-based diagnostic solutions and replacement of traditional methods with tests that require less effort and time and offer improved accuracy are increasing. Strategic collaborations between leading market players are yet another major factor supporting the growth of the segment. For instance, in 2021, Indical, one of the leading providers of innovative veterinary diagnostic solutions, acquired the Svanova product portfolio from Boehringer Ingelheim, becoming the exclusive provider of their veterinary testing products, including approximately twenty-five livestock ELISA assays.

Reference Laboratories Expected to Account for a Significant Market Share

The increase in demand for veterinary infectious disease diagnostic solutions by reference laboratories can be attributed to the rise in number of veterinary practitioners in various regions across the globe and increasing rate of adoption of pets. As per the collected records from the Humane Society and ASPCA, about 3.5 to 4.1 million dogs and cats are adopted every year in the United States. Additionally, the rising investments in laboratory services owing to the growing threat of infectious diseases in animals is further supporting the segment expansion. The growing requirement for high-volume specialty and routine veterinary testing is further expected to boost the demand for reference laboratories.

Future Market Scenario (2024 - 2031F)

Due to the lack of understanding of the mechanism of various infectious diseases in animals and the availability of durable and accurate diagnostic solutions, an increase in research efforts is essential for the provision of accurate diagnostic strategies for eradicating and controlling animal diseases. An increase in investment by pharmaceutical and diagnostic companies, veterinary practices, feline-oriented nonprofits, and academic institutions is also required for creating sustainable and effective antimicrobial stewardship solutions.

In 2023, Virginia Tech Animal Laboratory Services (ViTALS) was selected as part of the Partnership to Improve Early Detection of Emerging Diseases. ViTALS, along with four other laboratories, was selected for a new partnership between the National Bio and Agro-Defense Facility (NBAF) and the National Animal Health Laboratory Network (NAHLN). The partnership is expected to address the looming threat of infectious diseases and will emphasize next-generation sequencing for evaluating and developing diagnostic solutions for zoonotic and animal diseases.

Key Players Landscape and Outlook

Key participants in the veterinary infectious disease diagnostics market are Biomerieux S.A., Zoetis, Inc., IDEXX Laboratories, Inc., Indical Bioscience, and Heska Corporation. The market is expected to witness significant growth in the coming years owing to rising research and development activities and strategic collaborations between key market players.

For instance, in 2022, INDICAL BIOSCIENCE, one of the leading providers of veterinary diagnostic solutions, entered a partnership with Evonik, one of the leading specialty chemicals companies, to expand and develop precision monitoring solutions through the ScreenFloX(R) service in poultry. The ScreenFloX(R) service combines Evonik's Precision Livestock Farming portfolio with INDICAL's veterinary diagnostic capabilities to ensure the provision of proactive analysis of the flock's pathogen status.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Veterinary Infectious Disease Diagnostics Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Technology
    • 4.2.1.Molecular Diagnostics
    • 4.2.2.Immunodiagnostics
    • 4.2.3.Urinalysis
    • 4.2.4.Hematology
    • 4.2.5.Others
  • 4.3.By Animal Type
    • 4.3.1.Food Producing Animals
    • 4.3.2.Companion Animals
  • 4.4.By Infection Type
    • 4.4.1.Viral Infections
    • 4.4.2.Parasitic Infections
    • 4.4.3.Bacterial Infections
    • 4.4.4.Others
  • 4.5.By End-user
    • 4.5.1.Veterinary Laboratories and Clinics
    • 4.5.2.Point of Care/In House Testing
    • 4.5.3.Reference Laboratories
    • 4.5.4.Others
  • 4.6.By Region
    • 4.6.1.North America
    • 4.6.2.South America
    • 4.6.3.Europe
    • 4.6.4.Asia-Pacific
    • 4.6.5.Middle East & Africa
  • 4.7.By Company Market Share (%), 2023

5.Global Veterinary Infectious Disease Diagnostics Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Technology
      • 5.1.2.1.Molecular Diagnostics
      • 5.1.2.2.Immunodiagnostics
      • 5.1.2.3.Urinalysis
      • 5.1.2.4.Hematology
      • 5.1.2.5.Others
    • 5.1.3.By Animal Type
      • 5.1.3.1.Food Producing Animals
      • 5.1.3.2.Companion Animals
    • 5.1.4.By Infection Type
      • 5.1.4.1.Viral Infections
      • 5.1.4.2.Parasitic Infections
      • 5.1.4.3.Bacterial Infections
      • 5.1.4.4.Others
    • 5.1.5.By End-user
      • 5.1.5.1.Veterinary Laboratories and Clinics
      • 5.1.5.2.Point of Care/In House Testing
      • 5.1.5.3.Reference Laboratories
      • 5.1.5.4.Others
    • 5.1.6.United States*
      • 5.1.6.1.Market Size & Forecast
      • 5.1.6.1.1.By Value
      • 5.1.6.1.2.By Volume
      • 5.1.6.2.By Technology
      • 5.1.6.2.1.Molecular Diagnostics
      • 5.1.6.2.2.Immunodiagnostics
      • 5.1.6.2.3.Urinalysis
      • 5.1.6.2.4.Hematology
      • 5.1.6.2.5.Others
      • 5.1.6.3.By Animal Type
      • 5.1.6.3.1.Food Producing Animals
      • 5.1.6.3.2.Companion Animals
      • 5.1.6.4.By Infection Type
      • 5.1.6.4.1.Viral Infections
      • 5.1.6.4.2.Parasitic Infections
      • 5.1.6.4.3.Bacterial Infections
      • 5.1.6.4.4.Others
      • 5.1.6.5.By End-user
      • 5.1.6.5.1.Veterinary Laboratories and Clinics
      • 5.1.6.5.2.Point of Care/In House Testing
      • 5.1.6.5.3.Reference Laboratories
      • 5.1.6.5.4.Others
    • 5.1.7.Canada
    • 5.1.8.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East & Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Technology
  • 6.2.By Animal Type
  • 6.3.By Infection Type
  • 6.4.By End-user
  • 6.5.By Region

7.Macro Environment and Industry Structure

  • 7.1.Supply Demand Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat from New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Regulatory Approvals
  • 9.3.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Biomerieux S.A.
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products & Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus & Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Zoetis, Inc.
  • 13.3.IDEXX Laboratories, Inc.
  • 13.4.Indical Bioscience
  • 13.5.Heska Corporation
  • 13.6.IDVet
  • 13.7.Thermo Fisher Scientific Inc.
  • 13.8.Virbac
  • 13.9.Randox Laboratories Ltd.
  • 13.10.Neogen Corporation

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

14.Strategic Recommendations

15.About Us & Disclaimer